Neurogenetic and epigenetic aspects of cannabinoids

Authors

Catherine A Dennen, Jefferson Health Northeast
Kenneth Blum, The Kenneth Blum Behavioral Neurogenetic Institute
Abdalla Bowirrat, Ariel University
Jag Khalsa, The George Washington University
Panayotis K Thanos, State University of New York at Buffalo
David Baron, Western University of Health Sciences
Rajendra D Badgaiyan, Icahn School of Medicine Mt Sinai
Ashim Gupta, Future Biologics
Eric R Braverman, The Kenneth Blum Behavioral Neurogenetic Institute
Mark S Gold, Washington University School of Medicine in St. Louis

Journal

Epigenomes

Publication Date

8-26-2022

Volume

6

Issue

3

First Page

27

Document Type

Open Access Publication

DOI

10.3390/epigenomes6030027

Rights and Permissions

Dennen, C.A.; Blum, K.; Bowirrat, A.; Khalsa, J.; Thanos, P.K.; Baron, D.; Badgaiyan, R.D.; Gupta, A.; Braverman, E.R.; Gold, M.S. Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes 2022, 6, 27. https://doi.org/10.3390/epigenomes6030027 This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Dennen, Catherine A; Blum, Kenneth; Bowirrat, Abdalla; Khalsa, Jag; Thanos, Panayotis K; Baron, David; Badgaiyan, Rajendra D; Gupta, Ashim; Braverman, Eric R; and Gold, Mark S, "Neurogenetic and epigenetic aspects of cannabinoids." Epigenomes. 6, 3. 27 (2022).
https://digitalcommons.wustl.edu/oa_4/548